A bivalent cyclic RGD–siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts-Reference-Cited by-同舟云学术

A bivalent cyclic RGD–siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts

Author:

Liao Lumin¹,Cen Bohong²³,Li Guoxian¹,Wei Yuanyi²,Wang Zhen²,Huang Wen²,He Shuai²,Yuan Yawei³,Ji Aimin¹

Affiliation:

1. Department of Pharmacy, The Seventh Affiliated Hospital, Southern Medical University, Foshan, Guangdong, China

2. Department of Pharmacy, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China

3. Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, Guangdong, China

Funder

the National Natural Science Foundation of China

China Postdoctoral Science Foundation

the Natural Science Foundation of Guangdong, China

Guangzhou Key Medical Discipline Construction Project Fund

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

Reference34 articles.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Oral delivery of RNAi for cancer therapy;Cancer and Metastasis Reviews;2023-03-27